T-cell receptor cancer immunotherapy biotech
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Louis Bacon / Moore | 54 | New buy | 192,770 | $1,952,760 | 0.0% |
| Paul Tudor Jones / Tudor | 63 | Trimmed -1% | 66,434 | $672,976 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-16.